Description
The primary objective of this study is to evaluate whether OROS MPH (Concerta), relative to placebo, increases the effectiveness of standard smoking treatment (i.e., nicotine patch and individual smoking cessation counseling) in obtaining prolonged abstinence for smokers with ADHD. The study will involve an estimated 252 participants, recruited from approximately 6 sites.
|
Ohio Valley
Node (Lead)
Maryhaven, Inc.
Mayo Clinic
Long Island Node
New York State Psychiatric Institute
New York Node
VA New York Harbor Healthcare System
Northern New England
Node
MGH Pediatric Psychopharmacology
Oregon/Hawaii
Node
Native America Rehabilitation Association of NW Inc.
|